Kumaraguru Raja

Stock Analyst at Brookline Capital

(0)
# 4869
Out of 5,243 analysts
19
Total ratings
25.00%
Success rate
-28.01%
Average return
Main Sectors:
Top Industries:
16 Stocks
Name Action Price Target Current % Upside Ratings Updated
Quince Therapeutics
Initiates Coverage On: Buy
9
1.72 423.26% 1 Dec 18, 2024
Palisade Bio
Initiates Coverage On: Buy
38
1.75 2071.43% 1 Nov 20, 2024
SAB Biotherapeutics
Initiates Coverage On: Buy
8
3.45 131.88% 1 Jun 7, 2024
Forte Biosciences
Initiates Coverage On: Buy
100
16.8 495.24% 2 May 30, 2024
Hepion Pharmaceutica...
Downgrades: Hold
n/a
n/a n/a 1 Dec 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 1 Aug 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
150
1 14900% 2 Jul 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
15
4.22 255.45% 1 Jun 29, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
9
n/a n/a 1 Mar 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
21
4.25 394.12% 1 Jan 31, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
15
n/a n/a 1 Jan 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reinstates: Buy
90
25.15 257.85% 1 Dec 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
29 31
0.74 4089.19% 2 May 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
3360
1.38 243378.26% 1 Sep 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
320
n/a n/a 1 Mar 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Buy
120
n/a n/a 1 Mar 25, 2021